Prednisone Dosing for Pediatric Poison Ivy
For a child with poison ivy, prescribe oral prednisone at 1 mg/kg/day (maximum 60 mg/day) for 14-21 days with a gradual taper to prevent rebound dermatitis.
Dosing Algorithm
Initial Dose
- 1 mg/kg/day as a single morning dose (maximum 60 mg/day) 1
- Administer before 9 AM to align with natural cortisol rhythm and minimize HPA axis suppression 1
- Give with food or milk to reduce gastric irritation 1
Duration of Therapy
The evidence strongly supports longer courses over shorter courses:
- Minimum 14 days, preferably 14-21 days with gradual taper 2, 3, 4
- A 5-day course is insufficient and leads to significantly higher return visits 2, 4
- Shorter courses (1-13 days) increase odds of return visits by 30% (OR 1.30,95% CI 1.17-1.44) 4
Tapering Schedule
Critical to prevent rebound dermatitis 3:
After initial daily dosing for 7-10 days, taper over 7-14 additional days:
- Reduce by 25-33% every 2-3 days
- Example: 40 mg → 30 mg → 20 mg → 10 mg → 5 mg (each for 2-3 days)
- Never stop abruptly 1, 3
Severity-Based Approach
Mild-Moderate (Localized, <20% BSA)
- Consider topical corticosteroids (triamcinolone 0.1% or clobetasol 0.05%) instead 3
- Reserve oral steroids for treatment failures
Severe (>20% BSA, facial involvement, or extensive bullae)
- Systemic prednisone is required 3
- Provides relief within 12-24 hours 3
- Longer courses (15+ days) reduce need for additional medications by 33% (NNT 3.05) 2
Key Clinical Pitfalls
Underdosing Duration: The most common error is prescribing courses <14 days, which leads to:
- Rebound dermatitis when steroids are discontinued 3
- Return visits requiring additional treatment 2, 4
- Increased exposure to multiple medications 2
Weight-Based Considerations:
- For overweight children, dose based on ideal body weight to avoid unnecessary steroid exposure 5
- Maximum daily dose remains 60 mg regardless of weight 1
Timing: Morning administration is essential—exogenous corticosteroids suppress adrenal activity least when given during peak cortisol production (2-8 AM) 1
Evidence Quality Note
The provided guidelines [6-7] address nephrotic syndrome, not poison ivy, and should be disregarded for this indication. The relevant evidence comes from dermatology research 2, 3, 4 and FDA labeling 1. The 2014 randomized controlled trial 2 directly comparing 5-day vs 15-day courses provides the strongest evidence for duration, while the 2022 retrospective analysis of 115,885 claims 4 confirms real-world outcomes favoring longer courses.